Does every young woman presenting with a solid breast lump require a biopsy?six year experience of a regional breast unit
Association of Breast Surgery ePoster Library. Rose H. 05/13/19; 257073; P029
Dr. Heather Rose
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
P029
Topic: Benign disease
Introduction: Breast lumps are common in young women yet are frequently benign. Association of Breast Surgeons (ABS) guidance (2010) recommends that women <25 years with a presumed fibroadenoma satisfying benign criteria do not require a biopsy. We wanted to review the sensitivity of these criteria to detect benign lumps in the local population and explore whether the age could be extended to 35years. Methods From May 2012 to April 2013, details of all women aged ≤35years attending a symptomatic clinic with a solid breast lump were prospectively recorded. Variables included examination (P1-5), family history, ultrasound (U1-5) and pathology. ‘Benign' criteria included P1-3, size <3cm, static, no significant family history and U2. Initially all lumps were biopsied. Results: From May 2012-April 2013 there were 61 cases ≤35 years. 33(54%) satisfied ABS criteria and all were benign on biopsy. There were 4 cancers, all failed criteria. From these results, a ‘no biopsy requirement' for women ≤25 years was introduced inJune 2013. From May 2013-November 2018 there were 367 cases, 190 passed benign criteria (190/367, 52%). Of the remaining 177 that failed, all were biopsied. 158 were subsequently benign (158/367,43%) and 19 malignant (19/367,5%). From November 2014, the no biopsy requirement was extended to ≤30 years. To date 144 patients have been seen and discharged without biopsy.ConclusionOur results reaffirm ABS guidance for women under 25 years and provide evidence that this could be safely extended to include women aged 30 years and younger .
Topic: Benign disease
Introduction: Breast lumps are common in young women yet are frequently benign. Association of Breast Surgeons (ABS) guidance (2010) recommends that women <25 years with a presumed fibroadenoma satisfying benign criteria do not require a biopsy. We wanted to review the sensitivity of these criteria to detect benign lumps in the local population and explore whether the age could be extended to 35years. Methods From May 2012 to April 2013, details of all women aged ≤35years attending a symptomatic clinic with a solid breast lump were prospectively recorded. Variables included examination (P1-5), family history, ultrasound (U1-5) and pathology. ‘Benign' criteria included P1-3, size <3cm, static, no significant family history and U2. Initially all lumps were biopsied. Results: From May 2012-April 2013 there were 61 cases ≤35 years. 33(54%) satisfied ABS criteria and all were benign on biopsy. There were 4 cancers, all failed criteria. From these results, a ‘no biopsy requirement' for women ≤25 years was introduced inJune 2013. From May 2013-November 2018 there were 367 cases, 190 passed benign criteria (190/367, 52%). Of the remaining 177 that failed, all were biopsied. 158 were subsequently benign (158/367,43%) and 19 malignant (19/367,5%). From November 2014, the no biopsy requirement was extended to ≤30 years. To date 144 patients have been seen and discharged without biopsy.ConclusionOur results reaffirm ABS guidance for women under 25 years and provide evidence that this could be safely extended to include women aged 30 years and younger .
P029
Topic: Benign disease
Introduction: Breast lumps are common in young women yet are frequently benign. Association of Breast Surgeons (ABS) guidance (2010) recommends that women <25 years with a presumed fibroadenoma satisfying benign criteria do not require a biopsy. We wanted to review the sensitivity of these criteria to detect benign lumps in the local population and explore whether the age could be extended to 35years. Methods From May 2012 to April 2013, details of all women aged ≤35years attending a symptomatic clinic with a solid breast lump were prospectively recorded. Variables included examination (P1-5), family history, ultrasound (U1-5) and pathology. ‘Benign' criteria included P1-3, size <3cm, static, no significant family history and U2. Initially all lumps were biopsied. Results: From May 2012-April 2013 there were 61 cases ≤35 years. 33(54%) satisfied ABS criteria and all were benign on biopsy. There were 4 cancers, all failed criteria. From these results, a ‘no biopsy requirement' for women ≤25 years was introduced inJune 2013. From May 2013-November 2018 there were 367 cases, 190 passed benign criteria (190/367, 52%). Of the remaining 177 that failed, all were biopsied. 158 were subsequently benign (158/367,43%) and 19 malignant (19/367,5%). From November 2014, the no biopsy requirement was extended to ≤30 years. To date 144 patients have been seen and discharged without biopsy.ConclusionOur results reaffirm ABS guidance for women under 25 years and provide evidence that this could be safely extended to include women aged 30 years and younger .
Topic: Benign disease
Introduction: Breast lumps are common in young women yet are frequently benign. Association of Breast Surgeons (ABS) guidance (2010) recommends that women <25 years with a presumed fibroadenoma satisfying benign criteria do not require a biopsy. We wanted to review the sensitivity of these criteria to detect benign lumps in the local population and explore whether the age could be extended to 35years. Methods From May 2012 to April 2013, details of all women aged ≤35years attending a symptomatic clinic with a solid breast lump were prospectively recorded. Variables included examination (P1-5), family history, ultrasound (U1-5) and pathology. ‘Benign' criteria included P1-3, size <3cm, static, no significant family history and U2. Initially all lumps were biopsied. Results: From May 2012-April 2013 there were 61 cases ≤35 years. 33(54%) satisfied ABS criteria and all were benign on biopsy. There were 4 cancers, all failed criteria. From these results, a ‘no biopsy requirement' for women ≤25 years was introduced inJune 2013. From May 2013-November 2018 there were 367 cases, 190 passed benign criteria (190/367, 52%). Of the remaining 177 that failed, all were biopsied. 158 were subsequently benign (158/367,43%) and 19 malignant (19/367,5%). From November 2014, the no biopsy requirement was extended to ≤30 years. To date 144 patients have been seen and discharged without biopsy.ConclusionOur results reaffirm ABS guidance for women under 25 years and provide evidence that this could be safely extended to include women aged 30 years and younger .
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}